{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Huang YC"],"funding":["National Cheng Kung University Hospital","Ministry of Health and Welfare"],"pagination":["101381"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10990849"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["53"],"pubmed_abstract":["<h4>Introduction</h4>Lynch syndrome is caused by a germline mutation in mismatch repair (MMR) genes, leading to the loss of expression of MMR heterodimers, either MLH1/PMS2 or MSH2/MSH6, or isolated loss of PMS2 or MSH6. Concurrent loss of both heterodimers is uncommon, and patients carrying pathogenic variants affecting different MMR genes are rare, leading to the lack of cancer screening recommendation for these patients.Case presentation:Here, we reported a female with a family history of Lynch syndrome with <i>MLH1</i> c.676C > T mutation. She developed endometrial cancer at 37 years old, with loss of MLH1/PMS2 expression. Immunohistochemical staining on tumor samples incidentally detected the additional loss of MSH6 expression. Whole exome sequencing on genomic DNA from peripheral blo"],"journal":["Gynecologic oncology reports"],"pubmed_title":["Germline <i>MLH1</i> and <i>MSH6</i> mutations from two Lynch syndrome families identified in a patient with early-onset of endometrial cancer: A case report."],"pmcid":["PMC10990849"],"funding_grant_id":["MOHW112-TDU-B-221-124005","NCKUH-11210014"],"pubmed_authors":["Wu PY","Yeh YM","Cheng YM","Lin PC","Shen MR","Huang YC","Chen NS"],"additional_accession":[]},"is_claimable":false,"name":"Germline <i>MLH1</i> and <i>MSH6</i> mutations from two Lynch syndrome families identified in a patient with early-onset of endometrial cancer: A case report.","description":"<h4>Introduction</h4>Lynch syndrome is caused by a germline mutation in mismatch repair (MMR) genes, leading to the loss of expression of MMR heterodimers, either MLH1/PMS2 or MSH2/MSH6, or isolated loss of PMS2 or MSH6. Concurrent loss of both heterodimers is uncommon, and patients carrying pathogenic variants affecting different MMR genes are rare, leading to the lack of cancer screening recommendation for these patients.Case presentation:Here, we reported a female with a family history of Lynch syndrome with <i>MLH1</i> c.676C > T mutation. She developed endometrial cancer at 37 years old, with loss of MLH1/PMS2 expression. Immunohistochemical staining on tumor samples incidentally detected the additional loss of MSH6 expression. Whole exome sequencing on genomic DNA from peripheral blo","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Jun","modification":"2025-04-19T02:08:15.053Z","creation":"2025-04-07T12:41:55.242Z"},"accession":"S-EPMC10990849","cross_references":{"pubmed":["38584802"],"doi":["10.1016/j.gore.2024.101381"]}}